| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/13/2002 | EP1185557A1 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer |
| 03/13/2002 | EP1185554A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof |
| 03/13/2002 | EP1185545A1 Cd4-independent hiv envelope proteins as vaccines and therapeutics |
| 03/13/2002 | EP1185306A1 Use of viral vectors and charged molecules for gene therapy |
| 03/13/2002 | EP1185300A1 Method of treating carcinoma using antibody therapy and ameliorating side effects associated with such therapy |
| 03/13/2002 | EP1185299A1 Use of antibodies against cd20 for the treatment of the graft versus host disease |
| 03/13/2002 | EP1185298A2 Prevention and treatment of amyloidogenic disease |
| 03/13/2002 | EP1185297A2 Streptococcus pneumoniae proteins and vaccines |
| 03/13/2002 | EP1185296A2 Prevention and treatment of amyloidogenic disease |
| 03/13/2002 | EP1185290A1 Manufacturing method for intravenous immune globulin and resultant product |
| 03/13/2002 | EP1185285A1 49 human secreted proteins |
| 03/13/2002 | EP1185284A1 47 human secreted proteins |
| 03/13/2002 | EP0721342B1 Polypeptides of the semaphorin gene family |
| 03/13/2002 | CN1340103A Complex-forming proteins |
| 03/13/2002 | CN1339971A Application polyacrylamide gel for forming a capsule in the tissue of a mammal organism, method for cultivating cells and method for therapy of tumor and diabetes mellitus |
| 03/13/2002 | CN1339584A Recombined virus for specific proliferation and high efficiency expression of anti-cancer gene in tumor cells and its constitution method |
| 03/13/2002 | CA2319273A1 Live salmonella-based vaccines against escherichia coli o157:h7 |
| 03/12/2002 | US6355789 Cloned dna sequences related to the entire genomic rna of human immunodeficiency virus ii (hiv-2), polypeptides encoded by these dna sequences and use of these dna clones and polypeptides in diagnostic kits |
| 03/12/2002 | US6355684 Antimicrobial treatment for herpes simplex virus and other infectious diseases |
| 03/12/2002 | US6355625 Compositions of β-glucans and specific IGIV |
| 03/12/2002 | US6355622 Use of a melanoma differentiation associated gene (mda-7) for inducing apoptosis of a tumor cell |
| 03/12/2002 | US6355486 Geenerating genetically engineered microorganism; mix microorganism and preferential nucleotide sequences, electroporate mix, recover genetically engineered microorganism |
| 03/12/2002 | US6355463 UDP-N-acetylenolpyruvylglucosamine reductase |
| 03/12/2002 | US6355451 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 03/12/2002 | US6355450 Computer readable genomic sequence of Haemophilus influenzae Rd, fragments thereof, and uses thereof |
| 03/12/2002 | US6355445 Bacteriophage coupling to enzyme |
| 03/12/2002 | US6355444 Detecting cancer marker in sample; obtain hybridoma sample, incubate with antibody, detect bound antibody |
| 03/12/2002 | US6355414 Activating an immune response to antigens by nasopharyngeal administration of a particulated antigen and acemannan polysaccharide |
| 03/12/2002 | US6355271 Mixing an aqueous solution of calcium chloride with an aqueous solution of sodium citrate to form a mixture, adding an aqueous solution of sodium phosphate to the mixture to form a solution, stirring the solution |
| 03/12/2002 | US6355270 Particles for oral delivery of peptides and proteins |
| 03/12/2002 | US6355257 Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
| 03/12/2002 | US6355256 Compositions containing a p53 derived protein or peptide, an adjuvant, and interleukin-12 and uses thereof |
| 03/12/2002 | US6355255 Streptococcal C5a peptidase vaccine |
| 03/12/2002 | US6355254 Pathogenic Escherichia coli associated protein EspA |
| 03/12/2002 | US6355253 Bactericidal antibodies |
| 03/12/2002 | US6355248 Method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |
| 03/12/2002 | US6355247 Nucleic acid immunization using a virus-based infection/transfection system |
| 03/12/2002 | US6355246 Feline calicivirus isolated from cat urine and vaccines thereof |
| 03/12/2002 | US6355245 Glomerulonephritis,antibodies at low dosage |
| 03/12/2002 | US6355244 Methods and compositions for the treatment of psoriasis |
| 03/12/2002 | US6355238 Specific immune system modulation |
| 03/12/2002 | CA2189657C Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
| 03/12/2002 | CA2064077C T cell receptor peptides as therapeutics for autoimmune and malignant disease |
| 03/12/2002 | CA2034741C Therapeutic antibody based fusion proteins |
| 03/08/2002 | CA2357404A1 Method for growing or for removing circoviruses from biological material |
| 03/07/2002 | WO2002018954A2 Inhibition of cmv infection and dissemination |
| 03/07/2002 | WO2002018608A2 Methods for enhancing the efficacy of cancer therapy |
| 03/07/2002 | WO2002018600A1 Groes and groel homologs of francisella tularensis |
| 03/07/2002 | WO2002018595A2 Moraxella polypeptides and corresponding dna fragments and uses thereof |
| 03/07/2002 | WO2002018593A2 Modulation of fas and fasl expression |
| 03/07/2002 | WO2002018585A2 Packaging of positive-strand rna virus replicon particles |
| 03/07/2002 | WO2002018583A2 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 03/07/2002 | WO2002018576A2 Compositions and methods relating to lung specific genes |
| 03/07/2002 | WO2002018565A2 Regulation of human protein phosphatase iic-like enzyme |
| 03/07/2002 | WO2002018557A2 Human kinases |
| 03/07/2002 | WO2002018450A1 New cross-linked derivatives of hyaluronic acid |
| 03/07/2002 | WO2002018445A2 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design |
| 03/07/2002 | WO2002018444A2 Erbb4 antagonists |
| 03/07/2002 | WO2002018442A1 Stabilisation of immunoglobulins at a low ph |
| 03/07/2002 | WO2002018426A2 Rabbit hemorrhagic disease vaccine and antigens |
| 03/07/2002 | WO2002017962A2 Chemoprotectant for gastric toxicity |
| 03/07/2002 | WO2002017960A1 Vaccines against toxoplasma gondii |
| 03/07/2002 | WO2002017949A2 Novel functions for dp214 |
| 03/07/2002 | WO2002017935A2 A method of transplantation using chemotherapy-treated allogeneic cells that enhance immune responses without graft versus host disease |
| 03/07/2002 | WO2002017857A2 Methods and compositions for inhibiting angiogenesis |
| 03/07/2002 | WO2001094420B1 Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| 03/07/2002 | WO2001089457A3 Thrombopoietin mimetics |
| 03/07/2002 | WO2001087233A3 Anti-idiotypic antibody against fimh adhesin of uropathogenic type i-fimbriated escherichia coli, compositions and method of use thereof |
| 03/07/2002 | WO2001085777A3 Therapeutic pore-forming peptides |
| 03/07/2002 | WO2001077181A3 Anti-rhesus d monoclonal antibodies |
| 03/07/2002 | WO2001074855A3 Compositions and methods for dendritic cell-based immunotherapy |
| 03/07/2002 | WO2001072330A3 Method for immunostimulation using binding agents for the fc rec eptor of immunoglobulin a and for cancer cells or infections antigen |
| 03/07/2002 | WO2001068865A3 Fish vaccine against piscirickettsia salmonis |
| 03/07/2002 | WO2001068122A3 A method for reversing the immunosuppressive effects of the melanoma inhibitory activity 'mia' |
| 03/07/2002 | WO2001064872A3 Gene 2465: methods and compositions for the diagnosis and treatment of cardiovascular, hepatic and bone disease |
| 03/07/2002 | WO2001059130A3 Proteins producing an altered immunogenic response and methods of making and using the same |
| 03/07/2002 | WO2001058956A3 Antibodies that bind human interleukin-18 and methods of making and using |
| 03/07/2002 | WO2001058949A3 Heterologous polypeptide of the tnf family |
| 03/07/2002 | WO2001056599A3 Hyperthermia and immunotherapy for leukemias, lymphomas, and solid tumors |
| 03/07/2002 | WO2001055178A3 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 03/07/2002 | WO2001055177A3 Methods to identify ctl epitopes of hiv |
| 03/07/2002 | WO2001055174A3 Universal procedure for refolding recombinant proteins |
| 03/07/2002 | WO2001054716A3 Genetically engineered tumor cell vaccines |
| 03/07/2002 | WO2001046231A3 Polynucleotides and polypeptides encoded thereby |
| 03/07/2002 | WO2001044808A3 Methods of diagnosis and treatment by binding p75/airm1 |
| 03/07/2002 | WO2001043772A3 Method and device for producing an autologous immunization vaccine against cancerous diseases (tumour vaccine) |
| 03/07/2002 | WO2001043768A3 Vaccine composition comprising the toxoplasma protein sag3 |
| 03/07/2002 | WO2001040474A3 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 03/07/2002 | WO2001038360A3 Novel hcv non-structural polypeptide |
| 03/07/2002 | WO2001034184A3 Methods and compositions for protection against bovine herpesvirus 1 |
| 03/07/2002 | WO2001032692A3 Peptide mimics of conserved gonococcal epitopes and methods and compositions using them |
| 03/07/2002 | WO2001029220A3 Mage-a12 antigenic peptides and uses thereof |
| 03/07/2002 | WO2001011086A3 Methods of screening for angiogenesis modulators |
| 03/07/2002 | WO2001011049A3 Methods and compositions concerning canine interleukin 5 |
| 03/07/2002 | WO2000073344A9 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
| 03/07/2002 | US20020028943 For lowering serum lipid, cholesterol and/or triglyceride levels; treating atherosclerosis |
| 03/07/2002 | US20020028925 Hsv viral vector |
| 03/07/2002 | US20020028914 Chimeric toxins for targeted therapy |
| 03/07/2002 | US20020028784 Methods of preventing and treating viral infections using immunomodulatory polynucleotide sequences |
| 03/07/2002 | US20020028486 Adjusting affinity of immunoglobulins; generate expression vector, insert preferential sequences, express vector in cells, recover preferential immunoglobulin |